Study of 18F-Thretide PET/CT in Patients With Suspected Recurrence of Prostate Cancer
Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
This study evaluates the diagnostic performance and safety of 18F-Thretide PET/CT in patients
with suspected recurrence of prostate cancer who have negative or equivocal findings on
conventional imaging.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
First Affiliated Hospital of Fujian Medical University